Background: Post adenotonsillectomy coughing and laryngospasm in children entails deleterious sequelae, warranting continued search for effective prophylaxis. The aim was to determine the prophylactic efficacy of intravenous mini-dose (0.1 mg/kg) suxamethonium, 1.5 mg/kg lidocaine 1%, and their combination, against coughing and laryngospasm in children emerging from general anaesthesia after adenotonsillectomy.Methods: Ethical approval and parental written consent secured, 69 children, aged 1-6 years, of American Society of Anesthesiologists (ASA) class I were randomized into groups A, B, and C, of 23 each. All patients had general anaesthesia induced with propofol 2 mg/kg plus fentanyl 2 µ/kg, maintained with isoflurane 1-1.5% in 100% oxygen, and tracheal intubation facilitated by pancuronium 0.075 mg/kg. Two minutes after reversal dose of neostigmine, groups A, B and C respectively received 1.5 mg/kg lidocaine 1%, suxamethonium 0.1 mg/kg, and 1.5 mg/kg lidocaine 1% plus suxamethonium 0.1 mg/kg, intravenously. Tracheal extubation was done 90 seconds after study drug administration, and coughing and laryngospasm were assessed for 10 minutes using modified Minogue and Likert 4-point scales respectively.Results: All 69 subjects completed the study. The incidence of mild to moderate coughing was 22 (95.7%) in groups A and B, and 19 (82.6%) in group C, p=1.000. Laryngospasm occurred in none (0.0%) in group C, while in groups A and B its occurrence was 1(4.3%), p=1.000.Conclusions: Mini-dose suxamethonium or lidocaine 1.5 mg/kg prevented grade 3 coughing and laryngospasm; furthermore, their combination prevented grade 3 coughing and achieved zero incidence of laryngospasm.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.